Low-dose remimazolam plus remifentanil vs placebo plus remifentanil during gastroscopy in adults with obesity: A randomized trial
World Journal of Gastrointestinal Surgery · 04.11.2026
DOI: 10.4240/wjgs.125799 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift World Journal of Gastrointestinal Surgery, online erschienen am 04.11.2026. Verfasst von Xiao-Jing Dai und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dai, X., Bian, Z., Zhang, L., Zhao, M., & Yang, Y. (2026). Low-dose remimazolam plus remifentanil vs placebo plus remifentanil during gastroscopy in adults with obesity: A randomized trial. World Journal of Gastrointestinal Surgery. https://doi.org/10.4240/wjgs.125799
Vancouver
Dai X, Bian Z, Zhang L, Zhao M, Yang Y. Low-dose remimazolam plus remifentanil vs placebo plus remifentanil during gastroscopy in adults with obesity: A randomized trial. World Journal of Gastrointestinal Surgery. 2026. doi:10.4240/wjgs.125799
BibTeX
@article{Dai2026,
author = {Dai, Xiao-Jing and Bian, Zi-Jie and Zhang, Lian-Yi and Zhao, Man-Ting and Yang, Ying},
title = {Low-dose remimazolam plus remifentanil vs placebo plus remifentanil during gastroscopy in adults with obesity: A randomized trial},
journal = {World Journal of Gastrointestinal Surgery},
year = {2026},
doi = {10.4240/wjgs.125799}
}
EUVIMED